Gemcitabine/Cisplatin Versus Gemcitabine/Epirubicin for Non-Small Cell Lung Cancer (NSCLC)
Status:
Completed
Trial end date:
2005-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy of gemcitabine/cisplatin versus
gemcitabine/epirubicin in Stage IIIB/IV NSCLC in terms of response rate and overall survival.